Table 2 Pearson correlation coefficients and p-values of CLN2 signature metabolite abundances (normalized) and the MRIDSS, WCLS or age for all individuals (test and validation cohort).

From: Untargeted Metabolite Profiling of Cerebrospinal Fluid Uncovers Biomarkers for Severity of Late Infantile Neuronal Ceroid Lipofuscinosis (CLN2, Batten Disease)

Identification

Metabolite feature

WCLS

MRIDSS

Age (Months)

Pearson r

p-value

Pearson r

p-value

Pearson r

p-value

NAAG

Unknown 1

0.74

<0.0001

0.76

<0.0001

−0.7215

0.0002

NAAG-Adduct

Unknown 1 Adduct

0.75

<0.0001

0.78

<0.0001

0.1565

0.1976

Glycero-3-phosphoinositol

Unknown 2

0.6

0.003

0.57

0.0056

−0.5017

0.0174

NANA

N-Acetylneuraminic Acid

0.65

0.0009

0.59

0.0036

−0.3841

0.0776

NANA Dimer

Unknown 3

0.74

<0.0001

0.7

0.0003

−0.4997

0.0179

139.981

Unknown 4 parent

0.65

0.001

0.6

0.0029

−0.3848

0.077

95.988

Unknown 4

0.64

0.0015

0.57

0.006

−0.4181

0.0528

N-Acetylalanine

Unknown 5

0.66

0.0008

0.65

0.001

−0.5332

0.0106

N-Acetylglutamic Acid

 

0.11

0.6278

0.01

0.9585

−0.2377

0.2867

N-Acetylglycine

 

0.48

0.0224

0.28

0.2037

−0.37

0.0901

N-Acetylserine

 

0.67

0.0007

0.72

0.0001

−0.4748

0.0256

N-Acetylthreonine

 

0.55

0.0079

0.5

0.0175

−0.4243

0.0491